Pain
Feature
Elderly Americans carry heavier opioid burden
Those over age 65 years fill prescriptions for twice the amount, compared with younger adults.
Conference Coverage
Borderline personality disorder common in chronic pain patients
NATIONAL HARBOR, MD. – “The fact that one-fourth of individuals with [chronic noncancer pain] could have co-occurring BPD underscores the need for...
FDA/CDC
FDA OKs first orally disintegrating agent for rapid migraine relief
This is the first CGRP receptor antagonist available in a fast-acting orally disintegrating tablet for the acute treatment of migraine in adults...
FDA/CDC
FDA approves first IV migraine prevention drug
“The PROMISE-2 data showed that many patients can achieve reduction in migraine days of at least 75% and experience a sustained migraine...
Evidence-Based Reviews
Opioid use disorder in adolescents: An overview
Treatment needs to include interventions that address young patients’ unique needs.
News from the FDA/CDC
CDC: Opioid prescribing and use rates down since 2010
From the Journals
Cannabis for sleep: Short-term benefit, long-term disruption?
“This suggests that while cannabis may improve overall sleep, it’s also possible that there is a tolerance that develops with either very frequent...
Feature
FDA advisers set high bar for new opioids
Two days of FDA discussion over three new opioids seeking U.S. approval highlighted the barriers these drugs now face.
News from the FDA/CDC
FDA committee rejects oxycodegol, new opioid designed for less abuse
A novel opioid molecule designed to have less abuse potential with slower CNS entry received a unanimous FDA committee turn down.
Evidence-Based Reviews
Antipsychotics, dopamine, and pain
These medications’ effects on dopamine might help address chronic pain.
FDA/CDC
FDA okays ubrogepant for acute migraine treatment
ACHIEVE I and ACHIEVE II demonstrate efficacy.